Carisma and Moderna Expand Collaboration to Develop CAR-M Therapies for Autoimmune Diseases
Carisma Therapeutics has expanded its collaboration with Moderna to develop in vivo CAR-M therapies targeting autoimmune diseases. Building on successful preclinical research in oncology, Carisma’s proprietary chimeric...
Read More